新型α-氨酶抑制剂的开发:合成,分子对接和生物化学研究
K Ramakrishnan1, Reshma Rajan1, Lenin Nachimuthu1
1Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Cell biochemistry and biophysics
|April 29, 2025
概括
新的抗糖尿病化合物 (类似物3a-3j) 显示出强大的α-氨基酶抑制. 化合物3c和3d在和体外研究中显示出作为有效的抗糖尿病药物的显著潜力.
科学领域:
- 药用化学 医学化学
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病是一种日益严重的全球健康问题,需要开发新的治疗药物.
- 有效管理糖尿病需要创新的抗糖尿病药物来应对日益增长的患病率.
研究的目的:
- 为了合成和表征新的化学类似物 (3a-3j) 对于潜在的抗糖尿病活性.
- 评估这些新类型的in silico和in vitro生物特性,重点关注α-amylase抑制.
主要方法:
- 化合物3a-3j使用光谱技术 (NMR,FT-IR,GCMS,HRMS) 进行了合成和表征.
- 进行了in silico分子对接和in vitro测定,包括抗氧化剂,抗炎症,脂质修饰和α-amylase抑制.
- 通过IC50值量化α-amylase抑制活性,与标准药物acarbose进行比较.
主要成果:
- 化合物3c和3d在in silico和in vitro评估中表现出最高的抑制活性.
- 化合物3d和3e显示出强烈的α-氨基酶抑制,IC50值与阿卡尔相似.
- 所有合成的类似物 (3a-3j) 都表现出强烈的结合人胰腺α-氨基酶的活性部位.
结论:
- 新型类似物3a-3j具有作为分子开发新型抗糖尿病疗法的显著潜力.
- 化合物3c和3d是特别有前途的候选物,因为它们具有卓越的抑制作用.
- 这项研究为开发用于糖尿病管理的有效α-氨酶抑制剂提供了宝贵的见解.
相关概念视频
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


